Revenue: The sum of all revenue fields included for a company's operating activities.
Aurinia Pharmaceuticals Inc (AUPH) had Revenue of $62.47M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$62.47M |
$23.34M |
|
$8.57M |
|
$53.89M |
|
$36.19M |
|
$26.28M |
|
$-1.93M |
|
$24.35M |
|
$24.35M |
|
$23.34M |
|
$23.34M |
|
$23.34M |
|
$23.34M |
|
$26.28M |
|
$31.13M |
|
138.92M |
|
143.20M |
|
$0.17 |
|
$0.16 |
|
| Balance Sheet Financials | |
$405.76M |
|
$2.58M |
|
$99.09M |
|
$504.85M |
|
$68.41M |
|
$56.83M |
|
$86.25M |
|
$154.66M |
|
$350.19M |
|
$346.03M |
|
$350.19M |
|
137.75M |
|
| Cash Flow Statement Financials | |
$1.30M |
|
$31.03M |
|
$-49.34M |
|
$83.43M |
|
$66.43M |
|
$-17.00M |
|
$-3.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.93 |
|
-- |
|
-- |
|
0.14 |
|
0.20 |
|
86.27% |
|
42.07% |
|
42.07% |
|
-- |
|
38.98% |
|
37.37% |
|
$1.28M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.19 |
|
1.55 |
|
58.14 |
|
6.67% |
|
6.75% |
|
4.62% |
|
5.74% |
|
$2.54 |
|
$0.01 |
|
$0.01 |
|